NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · IEX Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: May 17, 2024, 4:00 PM
1.180
-0.030 (-2.48%)
After-hours: May 17, 2024, 5:07 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $20.80 million as of May 17, 2024. Its market cap has increased by 1.48% in one year.
Market Cap
20.80M
Enterprise Value
18.24M
1-Year Change
1.48%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $20.80M, a decrease of -67.80%. That is a compound annual growth rate of -37.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 18.60M | -1.06% |
May 16, 2024 | 18.80M | 2.17% |
May 15, 2024 | 18.40M | 6.98% |
May 14, 2024 | 17.20M | -2.82% |
May 13, 2024 | 17.70M | -2.21% |
May 10, 2024 | 18.10M | - |
May 9, 2024 | 18.10M | -4.23% |
May 8, 2024 | 18.90M | -4.55% |
May 7, 2024 | 19.80M | 1.54% |
May 6, 2024 | 19.50M | -4.88% |
May 3, 2024 | 20.50M | 5.13% |
May 2, 2024 | 19.50M | 0.52% |
May 1, 2024 | 19.40M | -6.73% |
Apr 30, 2024 | 20.80M | 5.05% |
Apr 29, 2024 | 19.80M | 4.76% |
Apr 26, 2024 | 18.90M | -2.58% |
Apr 25, 2024 | 19.40M | -5.83% |
Apr 24, 2024 | 20.60M | -1.44% |
Apr 23, 2024 | 20.90M | 0.48% |
Apr 22, 2024 | 20.80M | -4.59% |
Apr 19, 2024 | 21.80M | -6.84% |
Apr 18, 2024 | 23.40M | -4.88% |
Apr 17, 2024 | 24.60M | -3.15% |
Apr 16, 2024 | 25.40M | 8.09% |
Apr 15, 2024 | 23.50M | -4.47% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BriaCell Therapeutics | 22.05M |
American Shared Hospital Services | 21.98M |
ATI Physical Therapy | 21.98M |
MEI Pharma | 21.19M |
AIM ImmunoTech | 21.18M |
Lumos Pharma | 20.70M |
Sol-Gel Technologies | 20.68M |
Marpai | 20.62M |